GANYMED Pharmaceuticals' Series C - II Round

GANYMED Pharmaceuticals raised a round of funding on September 18, 2007. Investors include ATS Beteiligungsverwaltung.

Ganymed Pharmaceuticals is a biopharmaceutical company that researches, develops, and produces pharmaceutical products and therapeutic drugs for the treatment of solid cancers. It focuses on developin…

Articles about GANYMED Pharmaceuticals' Series C - II Round: